Cardinal Health (CAH) Tops Q4 EPS by 11c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cardinal Health (CAH) PT Raised to $119 at Deutsche Bank
August 15, 2024 1:41 PM EDTDeutsche Bank analyst George Hill raised the price target on Cardinal Health (NYSE: CAH) to $119.00 (from $115.00) while maintaining a Hold rating.
The analyst comments "FQ4 Earnings Beat and A Raise on FY25 Outlook: CAH reported F4Q results and raised its FY25 outlook and now sees full year EPS of $7.55 - $7.70 vs prior guidance of >$7.50 and the Streets estimate of $7.53. Within the additional 5-20c of EPS guide up, approximately 11c are attributed to lower interest expenses plus share... More
